Spruce Street Capital LP Q4 2025 Filing
Filed February 13, 2026
Portfolio Value
$302.7M
Holdings
27
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (27 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CDTXCIDARA THERAPEUTICS INC | 232,269 | $51.3M | 16.95% | |
| 2 | RLAYRELAY THERAPEUTICS INC | 2,984,125 | $25.2M | 8.34% | |
| 3 | LBRXLB PHARMACEUTICALS INC | 1,005,593 | $22.4M | 7.40% | |
| 4 | RLMDRELMADA THERAPEUTICS INC | 4,086,181 | $19.7M | 6.52% | |
| 5 | PCVXVAXCYTE INC | 400,360 | $18.5M | 6.10% | |
| 6 | KNSAKINIKSA PHARMACEUTICALS INTL | 434,982 | $17.9M | 5.93% | |
| 7 | EYPTEYEPOINT INC | 981,543 | $17.9M | 5.92% | |
| 8 | YB4PSAVARA INC | 2,411,093 | $14.5M | 4.80% | |
| 9 | ERASERASCA INC | 3,889,632 | $14.5M | 4.78% | |
| 10 | DNTHDIANTHUS THERAPEUTICS INC | 297,437 | $12.3M | 4.05% | |
| 11 | SRZNSURROZEN INC | 432,040 | $9.8M | 3.23% | |
| 12 | OCULOCULAR THERAPEUTIX INC | 783,999 | $9.5M | 3.14% | |
| 13 | SABSSAB BIOTHERAPEUTICS INC | 2,198,502 | $8.2M | 2.72% | |
| 14 | IKTINHIBIKASE THERAPEUTICS INC | 3,581,603 | $7.3M | 2.43% | |
| 15 | ELVNENLIVEN THERAPEUTICS INC | 446,084 | $6.9M | 2.27% | |
| 16 | NERVMINERVA NEUROSCIENCES INC | 1,655,500 | $6.7M | 2.20% | |
| 17 | ABVXABIVAX SA | 49,119 | $6.6M | 2.19% | |
| 18 | HELPCYBIN INC | 770,000 | $6.3M | 2.08% | |
| 19 | KALVKALVISTA PHARMACEUTICALS INC | 387,968 | $6.3M | 2.07% | |
| 20 | ENTAENANTA PHARMACEUTICALS INC | 389,687 | $6.1M | 2.03% | |
| 21 | ANROALTO NEUROSCIENCE INC | 222,844 | $4.0M | 1.31% | |
| 22 | LONAATHIRA PHARMA INC | 393,701 | $3.0M | 0.98% | |
| 23 | CNTACENTESSA PHARMACEUTICALS PLC | 77,997 | $1.9M | 0.64% | |
| 24 | ALECALECTOR INC | 1,117,986 | $1.7M | 0.58% | |
| 25 | LXEOLEXEO THERAPEUTICS INC | 175,000 | $1.7M | 0.57% | |
| 26 | IPSCCENTURY THERAPEUTICS INC | 1,421,532 | $1.4M | 0.47% | |
| 27 | STROSUTRO BIOPHARMA INC | 75,594 | $874K | 0.29% |